EUVIMEDEUVIMED entdecken
Crossref

Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing Indoleamine 2,3-Dioxygenase 1 via the E3 Ligase Split-Hand/Foot Malformation 3

Ricardo Almiron iD, Abbas Brahim Malloum, Saran Lotfollahzadeh iD, Kashvi Sethuraman, Arjun Sharma iD, Isaac Selinger iD, Anna Natrakul iD, Arjun Patel iD, David Jasen Wu Wong iD, Farihah Chowdhury iD, Asha Jose iD, Maria Del Carmen Piqueras iD und 5 weitere

Journal of the American Society of Nephrology · 21.08.2026

DOI: 10.1681/asn.0000001203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 21.08.2026. Verfasst von Ricardo Almiron und 16 weiteren Autor:innen. Beteiligte Einrichtung: Renal Section, Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts. Die Arbeit nennt 35 Literaturangaben. Gefördert von: NHLBI NIH HHS, NINR NIH HHS, AHA Cardio-Oncology SFRN CAT-HD Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Indoleamine 2,3-dioxygenase 1 is a central regulator of tryptophan metabolism and contributed to CKD-associated thromboinflammation and endothelial dysfunction. Indoxyl sulfate, a protein-bound uremic toxin, stabilized indoleamine 2,3-dioxygenase 1 by partially inhibiting its interaction with split-hand/foot malformation 3 and reducing ubiquitination. Targeting indoleamine 2,3-dioxygenase 1 degradation by modulating split-hand/foot malformation 3 may offer a novel therapeutic approach to mitigate CKD-associated arterial and venous thrombosis.

Background

The uremic milieu of CKD is characterized by the accumulation of protein-bound uremic toxins, which contribute to thrombosis. Indoxyl sulfate, a bona fide uremic toxin, upregulates indoleamine 2,3-dioxygenase 1 (IDO1), thereby augmenting kynurenine biogenesis. Both toxins activate tissue factor and thrombosis. Despite this pathogenic synergy, the mechanisms of indoxyl sulfate–mediated IDO1 stabilization remain undefined.

Methods

We employed targeted metabolomics, super-resolution microscopy, and gain- and loss-of-function experiments using nanoparticle-mediated gene delivery in mice to modulate split-hand/foot malformation 3 (SHFM3) expression. This was followed by carotid artery or inferior vena cava thrombosis assays in indoxyl sulfate–fed and adenine-induced CKD models.

Results

Among several F-box–containing E3 ligases, SHFM3 downregulated IDO1 in endothelial cells. SHFM3 constitutively interacted with IDO1, which is partially disrupted by indoxyl sulfate–induced nuclear sequestration of SHFM3 at concentrations corresponding to early-to-advanced CKD. SHFM3 interacted with the N-terminus of IDO1, ubiquitinated, and destabilized it. Indoxyl sulfate upregulated IDO1 activity, thereby increasing kynurenine biogenesis in N-terminus– and SHFM3-dependent manners. In an indoxyl sulfate–fed mouse model, endothelial cell–specific SHFM3 knockdown increased IDO1 and tissue factor while accelerating arterial thrombosis, and these effects were reversed by endothelial cell–specific SHFM3 overexpression. CKD mice exhibited 55% higher venous thrombogenicity than controls. Endothelial cell–specific SHFM3 overexpression significantly reversed these effects in control mice and, to a lesser extent, in CKD mice. Serum indoxyl sulfate levels significantly correlated with the global IDO1 activity and venous clot weights.

Conclusions

SHFM3 functions as an indoxyl sulfate–sensitive potent E3 ligase of IDO1, targeting it for degradation, even with partial interaction with IDO1 in the uremic milieu. This work also described a CKD-induced venous thrombosis model and supports the selective rewiring of uremic toxins in post-translational proteostasis, amplifying indoxyl sulfate–mediated arterial and venous thrombosis.

Schlagwörter

Stichwörter der Autor:innen

basic sciencechronic renal diseasemechanismsthrombosis

Autor:innen und Institutionen

  • Renal Section, Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Boston University Chemical Instrumentation Center, Metcalf Center for Science and Engineering, Boston, Massachusetts.
  • Injury Repair and Regeneration Research Section, Genetic Medicine and Nanotechnology Development Center, Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illi…

ORCID-Profile: Ricardo Almiron, Saran Lotfollahzadeh, Arjun Sharma, Isaac Selinger, Anna Natrakul, Arjun Patel, David Jasen Wu Wong, Farihah Chowdhury, Asha Jose, Maria Del Carmen Piqueras, Mohammad Shafiq, Nader Rahimi, You-Yang Zhao, Katya Ravid, Vipul C Chitalia

Förderung

  • NHLBI NIH HHS
  • NINR NIH HHS
  • AHA Cardio-Oncology SFRN CAT-HD Center
  • National Heart, Lung, and Blood Institute
  • National Institute of Nursing Research
  • Center of Cross Organ Vascular Pathology and by the Thrombosis and Hemostasis Affinity Research

Zitieren

APA

Almiron, R., Malloum, A. B., Lotfollahzadeh, S., Sethuraman, K., Sharma, A., Selinger, I., Natrakul, A., Patel, A., Wu Wong, D. J., Chowdhury, F., Jose, A., Carmen Piqueras, M. D., Shafiq, M., Rahimi, N., Zhao, Y. Y., Ravid, K., & Chitalia, V. C. (2026). Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing Indoleamine 2,3-Dioxygenase 1 via the E3 Ligase Split-Hand/Foot Malformation 3. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001203

Vancouver

Almiron R, Malloum AB, Lotfollahzadeh S, Sethuraman K, Sharma A, Selinger I, et al. Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing Indoleamine 2,3-Dioxygenase 1 via the E3 Ligase Split-Hand/Foot Malformation 3. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001203

BibTeX
@article{Almiron2026,
  author = {Almiron, Ricardo and Malloum, Abbas Brahim and Lotfollahzadeh, Saran and Sethuraman, Kashvi and Sharma, Arjun and Selinger, Isaac and Natrakul, Anna and Patel, Arjun and Wu Wong, David Jasen and Chowdhury, Farihah and Jose, Asha and Carmen Piqueras, Maria Del and Shafiq, Mohammad and Rahimi, Nader and Zhao, You-Yang and Ravid, Katya and Chitalia, Vipul C},
  title = {Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing Indoleamine 2,3-Dioxygenase 1 via the E3 Ligase Split-Hand/Foot Malformation 3},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000001203}
}
Kostenlos starten →